Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Prepaid Assets (2022 - 2025)

Stoke Therapeutics has reported Prepaid Assets over the past 4 years, most recently at $3.9 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $3.9 million for Q4 2025, down 64.96% from a year ago — trailing twelve months through Dec 2025 was $3.9 million (down 64.96% YoY), and the annual figure for FY2025 was $3.9 million, down 64.96%.
  • Prepaid Assets for Q4 2025 was $3.9 million at Stoke Therapeutics, down from $5.5 million in the prior quarter.
  • Over the last five years, Prepaid Assets for STOK hit a ceiling of $13.7 million in Q2 2025 and a floor of $2.6 million in Q4 2023.
  • Median Prepaid Assets over the past 4 years was $5.7 million (2023), compared with a mean of $7.6 million.
  • Biggest five-year swings in Prepaid Assets: tumbled 71.93% in 2023 and later surged 334.09% in 2024.
  • Stoke Therapeutics' Prepaid Assets stood at $3.0 million in 2022, then dropped by 13.33% to $2.6 million in 2023, then surged by 334.09% to $11.1 million in 2024, then tumbled by 64.96% to $3.9 million in 2025.
  • The last three reported values for Prepaid Assets were $3.9 million (Q4 2025), $5.5 million (Q3 2025), and $13.7 million (Q2 2025) per Business Quant data.